Status:
COMPLETED
Exercise, IMA and Sulfhydryl Biomarkers in Young Women
Lead Sponsor:
Duvenciler Anadolu Lİsesi
Conditions:
Healthy Young Women
Regular Exercise
Eligibility:
FEMALE
18-25 years
Brief Summary
Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (...
Detailed Description
Regular physical activity is widely recognized as a key determinant of human health, conferring benefits across cardiovascular, metabolic, endocrine, and immune systems. Beyond traditional outcomes, h...
Eligibility Criteria
Inclusion
- Healthy women aged 18-25 years
- For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
- For control group: No structured exercise background, only daily living activity
Exclusion
- History of chronic cardiovascular, metabolic, or endocrine disorders
- Smoking or alcohol abuse
- Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
- Irregular or intermittent exercise participation not meeting the defined threshold
Key Trial Info
Start Date :
January 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 20 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07181044
Start Date
January 20 2022
End Date
March 20 2022
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yüzüncü Yıl University, Central Research Laboratory
Van, Muş, Turkey (Türkiye), 49100